These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 10801955

  • 1. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections.
    Mocchegiani E, Muzzioli M.
    J Nutr; 2000 May; 130(5S Suppl):1424S-31S. PubMed ID: 10801955
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV.
    Mocchegiani E, Muzzioli M, Gaetti R, Veccia S, Viticchi C, Scalise G.
    Int J Immunopharmacol; 1999 Apr; 21(4):271-81. PubMed ID: 10408635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 6. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (natural killer activity and interleukin 2) in cervical carcinoma.
    Mocchegiani E, Ciavattini A, Santarelli L, Tibaldi A, Muzzioli M, Bonazzi P, Giacconi R, Fabris N, Garzetti GG.
    Br J Cancer; 1999 Jan; 79(2):244-50. PubMed ID: 9888464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial.
    Hadadi A, Ostovar A, Edalat Noor B, Rasoolinejad M, Haji Abdolbaghi M, Yousefi S, Khalili H, Manshoori G, Khashayar P, Alipour Z, Safari N.
    Acta Clin Belg; 2020 Jun; 75(3):170-176. PubMed ID: 30888253
    [Abstract] [Full Text] [Related]

  • 9. Cocaine reduces thymic endocrine function: another mechanism for accelerated HIV disease progression.
    Rafie C, Campa A, Smith S, Huffman F, Newman F, Baum MK.
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):815-22. PubMed ID: 21142650
    [Abstract] [Full Text] [Related]

  • 10. Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?
    Kirk O, Lundgren JD, Pedersen C, Nielsen H, Gerstoft J.
    AIDS; 1999 Sep 10; 13(13):1647-51. PubMed ID: 10509565
    [Abstract] [Full Text] [Related]

  • 11. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
    Zhang L, Huang Y, Liu Z, Liu W, Qin Q, Tao R.
    J Med Virol; 2015 Jul 10; 87(7):1158-67. PubMed ID: 25777553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. AIDS: Part II.
    Kessler HA, Bick JA, Pottage JC, Benson CA.
    Dis Mon; 1992 Oct 10; 38(10):691-764. PubMed ID: 1396036
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Schneider MM, Borleffs JC, Stolk RP, Jaspers CA, Hoepelman AI.
    Lancet; 1999 Jan 16; 353(9148):201-3. PubMed ID: 9923876
    [Abstract] [Full Text] [Related]

  • 15. [A changed pattern of opportunistic infections and malignancies in HIV-seropositive patients after the introduction of intensive anti-HIV-combination therapy].
    Borleffs JC, Schneider MM, Hoepelman IM.
    Ned Tijdschr Geneeskd; 1998 Oct 31; 142(44):2395-9. PubMed ID: 9864534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HIV infection and AIDS.
    Lloyd A.
    P N G Med J; 1996 Sep 31; 39(3):174-80. PubMed ID: 9795558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.